This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Yuanyuan Chu: Innovator in Fusion Protein Technology
Introduction
Yuanyuan Chu is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. Her innovative work has the potential to impact various medical applications, including cancer treatment.
Latest Patents
Yuanyuan Chu holds a patent for a fusion protein comprising a Caspase domain and a nuclear hormone receptor binding domain. This invention relates to a fusion protein that includes a Caspase domain or a functionally active variant and a ligand binding domain of a nuclear hormone receptor. The patent outlines methods and uses for this fusion protein, including its application in inducing apoptosis in cells and studying cellular functions.
Career Highlights
Yuanyuan Chu is affiliated with the Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt. Her work at this esteemed research institution has allowed her to explore innovative solutions in health and disease modeling. She has been recognized for her contributions to the scientific community and continues to advance research in her field.
Collaborations
Yuanyuan has collaborated with notable colleagues, including Wolfgang Wurst and Ralf Kuehn. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.
Conclusion
Yuanyuan Chu is a trailblazer in the field of fusion protein technology, with a focus on applications that could revolutionize cancer treatment and cellular research. Her contributions are paving the way for future advancements in biotechnology.